What is Pharmacogenomics?
Definition
Pharmacogenomics (PGx) is the study of how an individual's genetic makeup influences their response to medications. It combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, personalized drug therapies based on a patient's DNA.
Detailed Explanation
Every person metabolizes drugs differently. Some individuals break down medications too quickly, rendering them ineffective, while others metabolize them too slowly, leading to toxic buildup. Pharmacogenomics identifies the genetic variants — often single nucleotide polymorphisms (SNPs) — responsible for these differences. For example, the CYP2D6 gene encodes an enzyme that metabolizes roughly 25% of all clinically used drugs. Patients who carry loss-of-function alleles in CYP2D6 are classified as poor metabolizers, meaning standard doses of codeine, tamoxifen, or certain antidepressants may be ineffective or dangerous.
The clinical adoption of pharmacogenomics has accelerated significantly. The FDA now includes pharmacogenomic information on the labels of over 300 drugs, and guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC) provide genotype-based dosing recommendations. Tests for variants in genes like CYP2C19, VKORC1, DPYD, and HLA-B are routinely ordered before prescribing drugs such as clopidogrel, warfarin, fluorouracil, and abacavir. These tests help clinicians avoid adverse drug reactions that account for an estimated 6-7% of hospital admissions.
In peptide therapeutics, pharmacogenomics plays a growing role. Genetic variants can alter the target proteins that therapeutic peptides bind to, change the expression levels of receptors, or modify the proteases that degrade peptide drugs. PepFold integrates pharmacogenomic variant data directly into its peptide design pipeline: users submit rsIDs, and the system maps each variant to its functional impact on protein structure, then generates peptide candidates optimized for the patient's specific genetic context.
Related Terms
A single nucleotide polymorphism (SNP, pronounced 'snip') is a variation at a single position in a DNA sequence among individuals. SNPs are the most common type of genetic variation in humans, with approximately 4-5 million SNPs per individual genome and over 660 million cataloged in the dbSNP database.
What are CYP450 Enzymes?Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that catalyze the oxidative metabolism of the majority of clinically used drugs. In humans, 57 CYP genes encode enzymes that metabolize endogenous substrates (steroids, bile acids, fatty acids) and xenobiotics (drugs, environmental chemicals, dietary compounds). Five CYP enzymes — CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 — are responsible for metabolizing approximately 90% of all drugs in clinical use.
What is a Poor Metabolizer?A poor metabolizer (PM) is an individual who carries genetic variants resulting in little or no functional activity of a drug-metabolizing enzyme, most commonly a cytochrome P450 (CYP450) enzyme. Poor metabolizers process certain drugs much more slowly than normal metabolizers, which can lead to drug accumulation, increased plasma levels, prolonged drug effects, and a higher risk of adverse drug reactions at standard doses.
What is Personalized Medicine?Personalized medicine (also called precision medicine) is a medical model that uses an individual's genetic, environmental, and lifestyle information to guide clinical decisions. Rather than prescribing the same drug at the same dose to every patient with a given condition, personalized medicine selects therapies and dosages based on the patient's unique biological profile — particularly their genomic data.
What is ClinVar?ClinVar is a freely accessible public database maintained by the National Center for Biotechnology Information (NCBI) that aggregates information about the relationships between human genetic variants and observed health conditions (phenotypes). Submitters — including clinical laboratories, research groups, and expert panels — classify variants using a standardized five-tier system: pathogenic, likely pathogenic, uncertain significance (VUS), likely benign, and benign.
Related SNPs
Apply This Knowledge with PepFold
Submit rsIDs and get ranked peptide candidates with 3D structures and Fmoc-SPPS synthesis protocols in under 2 minutes.